BioMarin Pharmaceuticals Inc (BMRN) is a publicly traded Healthcare sector company. As of November 14, 2026, BMRN trades at $57.23 with a market cap of $11.09B and a P/E ratio of 152.15. BMRN moved +0.90% today. Year to date, BMRN is -2.79%; over the trailing twelve months it is +5.55%. Its 52-week range spans $49.26 to $73.18. Analyst consensus is buy with an average price target of $88.00. Rallies surfaces BMRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
22 analysts cover BMRN: 0 strong buy, 16 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $88.00.
| Metric | Value |
|---|---|
| Price | $57.23 |
| Market Cap | $11.09B |
| P/E Ratio | 152.15 |
| EPS | $0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.18 |
| 52-Week Low | $49.26 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.41B |
| Net Income | $72.97M |
| Gross Margin | 76.12% |
22 analysts cover BMRN: 0 strong buy, 16 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $88.00.